TRANSGENE (FR0005175080) — research page
FR · fr-cm-kg/XPAR/FR0005175080 · as of 2026-11-06
Identity and listing
The issuer is TRANSGENE, listed on Euronext Paris under ticker FR0005175080, with ISIN FR0005175080 and LEI 969500PDJW8N0FSGGK69. Its security type is Corporate, its segment is not on the record, its sector is NAF 72.11Z, and its jurisdiction is France (RCS-registered SA à conseil d'administration (s.a.i.)). The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | TRANSGENE | source · 2026-11-06 |
| exchange | Euronext Paris | source · 2026-11-06 |
| ticker | FR0005175080 | source · 2026-11-06 |
| ISIN | FR0005175080 | source · 2026-11-06 |
| LEI | 969500PDJW8N0FSGGK69 | source · 2026-11-09 |
| security type | Corporate | source · 2026-11-06 |
| segment | not on the record | |
| sector | NAF 72.11Z | source · 2026-11-06 |
| jurisdiction | France (RCS-registered SA à conseil d'administration (s.a.i.)) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 18 filings in the twelve months to 2026-11-06, across 13 filing days. The median gap between filing days is 21.0 days. The latest filing is dated 2026-11-05, 1 day before the record date, and is of type newswire_release. The exchange median is 8.0 days of cadence, 15.0 filings and 3 days of latency across 316 issuers on Euronext Paris. The sector median is 8.5 days of cadence, 20.0 filings and 2.0 days of latency across 24 issuers in NAF 72.11Z. By type, the window holds 16 newswire releases, 1 prospectus and 1 directors' dealings filing.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 18 | 21 | 1 |
| exchange median: Euronext Paris (316 issuers) | 15 | 8 | 3 |
| sector median: NAF 72.11Z (24 issuers) | 20 | 8.5 | 2 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-05 | newswire_release | First Patient Dosed in Phase 1 Trial Evaluating Transgene’s | |
| 2026-11-05 | newswire_release | First Patient Dosed in Phase 1 Trial Evaluating ... - Transgene | |
| 2026-11-03 | newswire_release | Transgene présentera des données précliniques au SITC ... | |
| 2026-11-03 | newswire_release | Transgene to Present Preclinical Data on Novel Oncolytic | |
| 2026-10-05 | newswire_release | Transgene présentera un poster sur les données ... |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of the issuer is not on the record, and neither is its location. The record carries the annual report link only, which is a source link and not a read. Auditor changes are not on the record.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, because this register has no lifecycle type map yet. The halt flag is clear: the issuer is listed, not halted.
Orderability
The outcome cannot be determined. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/fr/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.
rule acm-68000/fr/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's investor-relations page names 4 research houses: Kempen, Intron Health, Invest Securities and Oddo BHF.
| research house | analyst | source · read date |
|---|---|---|
| Kempen | Chiara Montironi | issuer page · 2026-11-12 |
| Intron Health | Naresh Chouhan | issuer page · 2026-11-12 |
| Invest Securities | Jamila El Bougrini | issuer page · 2026-11-12 |
| Oddo BHF | Martial Descoutures | issuer page · 2026-11-12 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (identity.exchange)
- 10.2
- https://recherche-entreprises.api.gouv.fr/search?q=317540581 (identity.jurisdiction)
- 10.3
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.4
- https://mcp.fr-cm-kg.ai/events/XPAR/FR0005175080 (the disclosure lines)
- 10.5
- https://live.euronext.com/en/ajax/haltedInstrument/getAjax/current (the halt flag)
- 10.6
- https://mcp.fr-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.7
- https://www.transgene.com/investors/ (coverage)
- 10.8
- https://mcp.fr-cm-kg.ai/record/XPAR/FR0005175080 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"FR0005175080"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:e31ae3bd271491ab.